M. Indrová
-
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová
2005, Vol. 51, Issue 1, pp. 19-24 -
Loss of Tumorigenicity of Murine Colon Carcinoma MC38/0 Cell Line after Transduction with a Retroviral Vector Carrying Murine IL-12 Genes
Elżbieta Pajtasz-Piasecka, A. Szyda, J. Rossowska, A. Krawczenko, M. Indrová, P. Grabarczyk, P. Wysocki, A. Mackiewicz, D. Duś
2004, Vol. 50, Issue 1, pp. 7-14 -
Local IFN-γ Therapy of HPV16-Associated Tumours
Romana Mikyšková, J. Bieblová, J. Šímová, M. Indrová, T. Jandlová, V. Vonka, M. Šmahel, J. Bubeník, L. Mendoza
2003, Vol. 49, Issue 1, pp. 26-32 -
Freezing and Thawing of Murine Bone Marrow-Derived Dendritic Cells Does Not Alter Their Immunophenotype and Antigen Presentation Characteristics
Luis Mendoza, J. Bubeník, M. Indrová, J. Bieblová, V. Vonka, J. Šímová
2002, Vol. 48, Issue 6, pp. 242-245
The following name might also represent this author:
Marie Indrová
-
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
Marie Indrová, M. Reiniš, J. Bubeník, T. Jandlová, J. Bieblová, V. Vonka, J. Velek
2004, Vol. 50, Issue 6, pp. 184-193 -
Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors
Marie Indrová, R. Mikyšková, T. Jandlová, V. Vonka, J. Bubeník, J. Bieblová
2003, Vol. 49, Issue 6, pp. 217-222
